Q2 Solutions赞助的临床试验
总计798个结果
-
GlaxoSmithKlinePPD; ERT: Clinical Trial Technology Solutions; Q2 Solutions撤销
-
GlaxoSmithKlineQ2 Solutions; York Bioanalytical Solution; BI Medical.Inc; SRL Mediserch.Inc; Parexel International...完全的
-
Vaxess TechnologiesICON plc; Q2 Solutions; Centricity Research完全的
-
GlaxoSmithKlineQuintiles, Inc.; ERT: Clinical Trial Technology Solutions; Q2 Solutions; HemoCue完全的
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, Inc完全的
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD); 4Clinics招聘中胃癌 | 大肠癌 | 非小细胞肺癌 | 头颈部鳞状细胞癌 | HNSCC | 晚期/转移性实体瘤 | 胃食管结合部癌美国, 西班牙, 比利时, 法国, 荷兰, 英国
-
Sinocelltech Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Parexel; Q2 Solutions完全的
-
Reata, a wholly owned subsidiary of BiogenCelerion; Q2 Solutions; Altasciences Company Inc.完全的
-
Swedish Orphan BiovitrumPRA Health Sciences; Cromsource; BioMérieux; Q2 Solutions; Cytel Inc.; ABF Pharmaceutical Services GmbH终止
-
Gene Solutions招聘中
-
InLight Solutions未知
-
Gene Solutions招聘中非小细胞肺癌 | IIIB 期非小细胞肺癌 | IV 期非小细胞肺癌 | IIIC 期非小细胞肺癌 | 酪氨酸激酶抑制剂越南
-
Ephemeral Solutions Inc.完全的